¼¼°èÀÇ Ç÷¼ÒÆÇdzºÎÇ÷Àå(PRP) ½ÃÀå º¸°í¼­(2024³â)
Platelet Rich Plasma Global Market Report 2024
»óǰÄÚµå : 1527096
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 7,234,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,851,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,469,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷¼ÒÆÇdzºÎÇ÷Àå(PRP) ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ±Þ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2028³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 17.3%·Î ¼ºÀåÇÏ¿© 13¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ½ºÆ÷Ã÷ ºÎ»ó À¯º´·ü Áõ°¡, Á¤Çü¿Ü°ú Áúȯ À¯º´·ü Áõ°¡, ¹Ì¿ë ¹× ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ³ëÈ­ °ü·Ã Áúȯ Áõ°¡·Î ÀÎÇÑ Àα¸ °í·ÉÈ­, PRPÀÇ È¿´ÉÀ» µÞ¹ÞħÇÏ´Â ÀÓ»ó½ÃÇè Áõ°¡ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â PRP Ä¡·á ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü, ÃÖ±Ù µ¿Çâ, PRP Ä¡·áÀÇ »õ·Î¿î ¿ëµµ ¹ß°ß, ÁøÇà ÁßÀÎ ¿¬±¸ ¹× Çõ½Å, ÀÌ ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.

½ºÆ÷Ã÷ ºÎ»ó ¹ß»ý·ü Áõ°¡´Â ÇâÈÄ ¸î ³âµ¿¾È ´Ù Ç÷¼ÒÆÇ Ç÷Àå ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ºÆ÷Ã÷ ºÎ»ó Áõ°¡´Â ½ºÆ÷Ã÷ Âü¿© Áõ°¡, û¼Ò³â ½ºÆ÷Ã÷ ÇÁ·Î±×·¥ µî·Ï Áõ°¡, ³ëÈ­ °ü·Ã ¹®Á¦, ºÒÃæºÐ ÇÑ ÄÚĪ ¹× °¨µ¶°ú °°Àº ¿äÀο¡ ±âÀÎÇϸç, PRP ¿ä¹ýÀº Á¶Á÷ º¹±¸ ¹× Àç»ýÀ» ÃËÁøÇÏ°í ¿°ÁõÀ» ÁÙÀ̰í ÈûÁÙ°ú ÀδëÀÇ Ä¡À¯ °úÁ¤À» ÃËÁøÇÏ¿© ½ºÆ÷Ã÷ ºÎ»ó ȸº¹¿¡ Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ºÎ»ó ȸº¹À» µ½´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ Ä¡·á´Â ¿îµ¿¼±¼ö¿¡°Ô ÃÖ¼Ò Ä§½ÀÀû Ä¡·á ¿É¼ÇÀ» Á¦°øÇϰí ȸº¹ ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹°¡¾ÈÀüÀ§¿øÈ¸ÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2021³â¿¡´Â ½ºÆ÷Ã÷ ¹× ·¹Å©¸®¿¡ÀÌ¼Ç Àåºñ·Î ÀÎÇÑ ºÎ»óÀÌ 3231¸¸ 1,885°Ç, 2021³â¿¡´Â 363¸¸ 1,970°ÇÀ¸·Î Áõ°¡ÇÏ¿© ½ºÆ÷Ã÷ ºÎ»óÀÇ À¯º´·ü Áõ°¡¿Í ±×¿¡ µû¸¥ PRP Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

PRP ½ÃÀåÀ» °³Ã´ÇÏ´Â ½ÅÈï±¹ ±â¾÷µéÀº ƯÈ÷ ¹Ì¿ë ºÐ¾ß¿¡¼­ Áõ°¡ÇÏ´Â PRP Ä¡·á ¼ö¿ä¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¼ºÇ° ÇöóÁ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ½ÃÆÇµÇ´Â PRP Á¦Ç°Àº °³º°ÀûÀ¸·Î ÁغñÇÒ Çʿ䰡 ¾ø°í, ÀϰüµÈ Ç÷¼ÒÆÇ ¾ç°ú È¿´ÉÀ» Á¦°øÇϸç, Ä¡·á¿ëÀ¸·Î Æí¸®ÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 4T MedicalÀº 2023³â 7¿ù ¶óº§ÀÌ ºÎÂøµÈ PRP ŰƮ¸¦ Ãâ½ÃÇÒ ¿¹Á¤À̸ç, ÀÌ Å°Æ®´Â ÇǺΠȸÃá°ú È¿À²ÀûÀÎ Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇØ ÀÚ°¡ PRP¸¦ ÁغñÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ Å°Æ®¿¡´Â Ç×ÀÀ°í Å×½ºÆ® Æ©ºê¿Í äÇ÷¿¡ ÇÊ¿äÇÑ ¼Ò¸ðǰÀÌ Æ÷ÇԵǾîÀÖ¾î Ä¡À¯, Äݶó°Õ »ý¼º, ÇǺΠź·Â ¹× ¸ð¹ß ¼ºÀåÀ» °¡¼ÓÇÏ´Â PRP¸¦ ½±°Ô ½Äº°Çϰí ÁÖÀÔ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦35Àå ÇâÈÄ Àü¸Á°ú ÀáÀçÀûÀÎ ºÐ¼®

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Platelet-rich plasma (PRP) is a concentrated form of plasma that contains platelets, growth factors, and bioactive proteins. It is obtained from the patient's own blood through centrifugation, which separates the platelets from other blood components. PRP finds use in medical and cosmetic treatments because of its healing and tissue regeneration properties.

The primary variations of platelet-rich plasma include pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, leukocyte-rich fibrin, among others. Pure platelet-rich plasma denotes a concentrated solution of platelets and plasma, devoid of red and white blood cells, thus ensuring heightened platelet-derived growth factors. It can be sourced from allogeneic, autologous, or homologous platelet-rich plasma for applications in cosmetic surgery, aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery, and other medical uses, utilized by hospitals, clinics, research institutes, and other end-users.

The platelet rich plasma market research report is one of a series of new reports from The Business Research Company that provides platelet rich plasma market statistics, including the platelet rich plasma industry global market size, regional shares, competitors with platelet rich plasma market share, detailed platelet rich plasma market segments, market trends, and opportunities, and any further data you may need to thrive in the platelet rich plasma industry. These platelet rich plasma market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The platelet rich plasma market size has grown rapidly in recent years. It will grow from $0.61 billion in 2023 to $0.71 billion in 2024 at a compound annual growth rate (CAGR) of 17.1%. The historic period saw growth driven by factors such as increasing demand for minimally invasive procedures, a rise in chronic conditions such as arthritis, heightened attention to pain management and injury recovery, expanded usage of PRP in veterinary medicine, and increased disposable income and healthcare spending.

The platelet rich plasma market size is expected to see rapid growth in the next few years. It will grow to $1.34 billion in 2028 at a compound annual growth rate (CAGR) of 17.3%. In the forecast period, growth is expected to stem from several factors, including the rising prevalence of sports injuries, a higher incidence of orthopedic disorders, increased demand for cosmetic and aesthetic procedures, an aging population leading to more age-related conditions, and a growing body of clinical trials supporting the effectiveness of PRP. Major trends anticipated during this time include technological advancements in PRP processing systems, recent developments, the discovery of new applications for PRP therapy, ongoing research and innovation, and increased investments in this field.

The increasing incidence of sports injuries is expected to drive the growth of the platelet-rich plasma (PRP) market in the coming years. The rise in sports injuries can be attributed to factors such as increased participation in sports, higher enrollment in youth sports programs, age-related issues, and inadequate coaching and supervision. PRP therapy plays a significant role in aiding sports injury recovery by promoting tissue repair and regeneration, reducing inflammation, and accelerating the healing process of tendons and ligaments. This therapy offers athletes a minimally invasive treatment option with the potential for faster recovery times. For instance, data from the National Safety Council shows that in 2021, there were 3,231,885 sports and recreational equipment injuries, which increased to 3,631,970, highlighting the growing prevalence of sports injuries and the resulting demand for PRP therapy.

Leading companies in the PRP market are focusing on developing off-the-shelf plasma products to meet the increasing demand for PRP treatments, particularly in the aesthetics sector. Off-the-shelf PRP products provide a convenient solution for therapeutic use, offering consistent platelet dose and potency without the need for individual preparation. For example, 4T Medical launched a labeled PRP kit in July 2023, designed to prepare autologous PRP for promoting skin rejuvenation and efficient healing. The kit includes anticoagulant test tubes and necessary consumables for blood drawing, facilitating the identification and injection of PRP to enhance healing, collagen production, skin tightening, and hair growth.

In March 2023, Kedaara Capital acquired a majority stake in Oliva Skin & Hair Clinic, aiming to support Oliva's growth in becoming India's leading aesthetic dermatology player with a pan-India reach. Oliva Skin & Hair Clinic provides PRP hair treatment solutions, aligning with the growing demand for PRP therapies in the aesthetics and dermatology sectors.

Major companies operating in the platelet rich plasma market are Johnson & Johnson Services Inc., Stryker, Zimmer Biomet, Terumo Corporation, Arthrex Inc., Pall Corporation, Globus Medical, LifeNet Health, Exactech Inc., BioBridge Global, Regen Lab SA, Celling Biosciences Inc., Eclipse Aesthetics LLC, Regenexx, Isto Biologics, Royal Biologics, Apex Biologix, EmCyte Corporation, Medira Ltd., Nuo Therapeutics Inc., Juventix Regenerative Medical LLC., Estar Medical, Dr PRP USA LLC, MDBiologix, Vivostat A/S

North America was the largest region in the platelet-rich plasma market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet rich plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the platelet rich plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The platelet-rich plasma market includes revenues earned by entities by providing PRP hair restoration, skin rejuvenation, acne scar treatment, orthopedic treatments, post-surgical healing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Platelet Rich Plasma Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on platelet rich plasma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for platelet rich plasma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The platelet rich plasma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Scope

Table of Contents

1. Executive Summary

2. Platelet Rich Plasma Market Characteristics

3. Platelet Rich Plasma Market Trends And Strategies

4. Platelet Rich Plasma Market - Macro Economic Scenario

5. Global Platelet Rich Plasma Market Size and Growth

6. Platelet Rich Plasma Market Segmentation

7. Platelet Rich Plasma Market Regional And Country Analysis

8. Asia-Pacific Platelet Rich Plasma Market

9. China Platelet Rich Plasma Market

10. India Platelet Rich Plasma Market

11. Japan Platelet Rich Plasma Market

12. Australia Platelet Rich Plasma Market

13. Indonesia Platelet Rich Plasma Market

14. South Korea Platelet Rich Plasma Market

15. Western Europe Platelet Rich Plasma Market

16. UK Platelet Rich Plasma Market

17. Germany Platelet Rich Plasma Market

18. France Platelet Rich Plasma Market

19. Italy Platelet Rich Plasma Market

20. Spain Platelet Rich Plasma Market

21. Eastern Europe Platelet Rich Plasma Market

22. Russia Platelet Rich Plasma Market

23. North America Platelet Rich Plasma Market

24. USA Platelet Rich Plasma Market

25. Canada Platelet Rich Plasma Market

26. South America Platelet Rich Plasma Market

27. Brazil Platelet Rich Plasma Market

28. Middle East Platelet Rich Plasma Market

29. Africa Platelet Rich Plasma Market

30. Platelet Rich Plasma Market Competitive Landscape And Company Profiles

31. Platelet Rich Plasma Market Other Major And Innovative Companies

32. Global Platelet Rich Plasma Market Competitive Benchmarking

33. Global Platelet Rich Plasma Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Platelet Rich Plasma Market

35. Platelet Rich Plasma Market Future Outlook and Potential Analysis

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â